[Coagulation in the context of cancer].
D000925:Anticoagulants / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001792:Blood Platelets / Q000503:physiopathology; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005170:Factor X / Q000502:physiology; D005337:Fibrin / Q000502:physiology; D005342:Fibrinolysis; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000098:blood supply / Q000150:complications* / Q000188:drug therapy; D009389:Neovascularization, Pathologic; D013924:Thrombophlebitis / Q000209:etiology; D013925:Thromboplastin / Q000502:physiology
D000925:Anticoagulants; D005170:Factor X; D005337:Fibrin; D013925:Thromboplastin
La coagulación en el perimundo del cáncer.